Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease

This study has been completed.

Study NCT00381238 Information provided by GlaxoSmithKline

First Received: September 26, 2006 Last Updated: April 19, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2009
Primary Completion Date:	February 2009 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: March 29, 2010